BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19175731)

  • 1. Combined gemcitabine and carboplatin therapy for carcinomas in dogs.
    Dominguez PA; Dervisis NG; Cadile CD; Sarbu L; Kitchell BE
    J Vet Intern Med; 2009; 23(1):130-7. PubMed ID: 19175731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of gemcitabine and carboplatin doublet therapy in cats with carcinomas.
    Martinez-Ruzafa I; Dominguez PA; Dervisis NG; Sarbu L; Newman RG; Cadile CD; Kitchell BE
    J Vet Intern Med; 2009; 23(3):570-7. PubMed ID: 19298611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
    Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
    Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer.
    Ritch P; Rudin CM; Bitran JD; Edelman MJ; Makalinao A; Irwin D; Lilenbaum R; Peterson P; John WJ
    Lung Cancer; 2006 May; 52(2):173-80. PubMed ID: 16507327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer.
    Dudek AZ; Larson T; Keshtgarpour M; Kumar P
    Am J Clin Oncol; 2007 Oct; 30(5):481-6. PubMed ID: 17921707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer.
    Karapanagiotou EM; Charpidou A; Tzannou I; Dilana K; Kotteas E; Tourkantonis I; Kosmas E; Provata A; Syrigos K
    Med Oncol; 2008; 25(3):303-8. PubMed ID: 18204976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer.
    Abratt RP; Lee JS; Han JY; Tsai CM; Boyer M; Mok T; Kim SW; Lee JS; Brnabic AJ; Reece WH; Lehnert M
    J Thorac Oncol; 2006 Feb; 1(2):135-40. PubMed ID: 17409842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of paclitaxel, carboplatin and gemcitabine in patients who have received prior cisplatin-based chemotherapy].
    Ito H; Aoki Y; Oyama N; Miwa Y; Akino H; Yokoyama O
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):481-4. PubMed ID: 21403460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.
    Bailey D; Erb H; Williams L; Ruslander D; Hauck M
    J Vet Intern Med; 2003; 17(2):199-205. PubMed ID: 12683621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of low-dose gemcitabine in 6-hour infusion and carboplatin is a favorable option for patients in poor performance status with advanced non-small cell lung cancer.
    Wu ZY; Guan HH; Lin ZX; Yang HK; Zhou L; Cai QC
    J Chemother; 2014 Oct; 26(5):306-11. PubMed ID: 24075685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
    Marconato L; Zini E; Lindner D; Suslak-Brown L; Nelson V; Jeglum AK
    J Am Vet Med Assoc; 2011 Apr; 238(8):1004-10. PubMed ID: 21492043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
    Bamias A; Moulopoulos LA; Koutras A; Aravantinos G; Fountzilas G; Pectasides D; Kastritis E; Gika D; Skarlos D; Linardou H; Kalofonos HP; Dimopoulos MA
    Cancer; 2006 Jan; 106(2):297-303. PubMed ID: 16342065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study.
    Ng EW; Sandler AB; Robinson L; Einhorn LH
    Am J Clin Oncol; 1999 Dec; 22(6):550-3. PubMed ID: 10597737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of first-line chemotherapy with weekly carboplatin plus gemcitabine in advanced non-small cell lung cancer.
    Mori K; Kamiyama Y; Kasai H; Kodama T
    Chemotherapy; 2012; 58(1):78-83. PubMed ID: 22377616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
    Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T
    Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
    Xu N; Shen P; Zhang XC; Yu LF; Bao HY; Shi GM; Huang S; Chen J; Mou HB; Fang WJ
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):1-7. PubMed ID: 16614849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma.
    Tsuruta H; Inoue T; Narita S; Horikawa Y; Saito M; Obara T; Numakura K; Maita S; Satoh S; Tsuchiya N; Habuchi T
    Int J Clin Oncol; 2011 Oct; 16(5):533-8. PubMed ID: 21431341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
    McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
    J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes.
    Chan D; Yeo WL; Tiemsim Cordero M; Wong CI; Chuah B; Soo R; Tan SH; Lim SE; Goh BC; Lee SC
    Invest New Drugs; 2010 Dec; 28(6):859-65. PubMed ID: 19705063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.
    Gajra A; Mehdi SA; Kirshner J; Newman N; Graziano SL
    Lung Cancer; 2001 May; 32(2):189-96. PubMed ID: 11325490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.